Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed Papers

Amyloid fibrils activate B-1a lymphocytes to ameliorate inflammatory brain disease.
Persisting myelin oligodendrocyte glycoprotein antibodies in aquaporin-4 antibody negative pediatric neuromyelitis optica.
Magnetic resonance imaging pattern in natalizumab-associated progressive multifocal leukoencephalopathy.
Treatment of neurological injury with thymosin β4.
A newborn with Pierre Robin sequence after preconceptional mitoxantrone exposure of a female with multiple sclerosis.
Glatiramer acetate after mitoxantrone induction improves MRI markers of lesion volume and permanent tissue injury in MS.
Tobacco Smoke-Induced Brain White Matter Myelin Dysfunction: Potential Co-Factor Role of Smoking in Neurodegeneration.
Glatiramer acetate (Copaxone) induces degenerate, Th2-polarized immune responses in patients with multiple sclerosis.
Pericytes are required for blood-brain barrier integrity during embryogenesis.
Immunosuppressive properties of mesenchymal stem cells: advances and applications.
[Experience of using genfaxon for treating patients with relapsing-remitting multiple sclerosis in the Russian Federation.]
Biogen Idec submits application to FDA for approval of PLEGRIDY™ (peginterferon beta-1a) in multiple sclerosis
Neuroprotection with glatiramer acetate: evidence from the PreCISe trial.
The N-terminal pro-brain natriuretic peptide as a marker of mitoxantrone-induced cardiotoxicity in multiple sclerosis patients.
Raxone®/Catena® (idebenone)
Thrombotic microangiopathy associated with use of interferon-beta.
Integrated genomic and prospective clinical studies show the importance of modular pleiotropy for disease susceptibility, diagnosis and treatment.
The potential teratogenic effects of interferon beta-1a (IFNβ-1a) and interferon beta-1b (IFNβ-1b) on in vitro embryonic development.
Evaluation of pattern-reversal visual evoked potential in patients with neuromyelitis optica.
Novel MS Drug Offers Good Functional Outcomes
Gastrointestinal Tolerability of Delayed-Release Dimethyl Fumarate in a Multicenter, Open-Label Study of Patients with Relapsing Forms of Multiple Sclerosis (MANAGE).
New Drugs Online report for idebenone
Altered serum content of brain-derived neurotrophic factor isoforms in multiple sclerosis.
Complex antibody profiling to predict clinical outcome in childhood ADS.
Glatiramer acetate after induction therapy with mitoxantrone in relapsing multiple sclerosis.

Pages